164 related articles for article (PubMed ID: 7847183)
1. Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation.
Hoult JR; Forder RA; de las Heras B; Lobo IB; Payá M
Agents Actions; 1994 Aug; 42(1-2):44-9. PubMed ID: 7847183
[TBL] [Abstract][Full Text] [Related]
2. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Oketani K; Nagakura N; Harada K; Inoue T
Eur J Pharmacol; 2001 Jun; 422(1-3):209-16. PubMed ID: 11430933
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase.
Salmon JA; Tilling LC; Moncada S
Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019
[TBL] [Abstract][Full Text] [Related]
5. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
6. Effect of manoalide on human 5-lipoxygenase activity.
Cabré F; Carabaza A; Suesa N; García AM; Rotllan E; Gómez M; Tost D; Mauleón D; Carganico G
Inflamm Res; 1996 May; 45(5):218-23. PubMed ID: 8737743
[TBL] [Abstract][Full Text] [Related]
7. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of leukocyte eicosanoid generation and radical scavenging activity by gnaphalin, a lipophilic flavonol isolated from Helichrysum picardii.
de la Puerta R; Forder RA; Hoult JR
Planta Med; 1999 Aug; 65(6):507-11. PubMed ID: 10483368
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of eicosanoid formation in human polymorphonuclear leukocytes by high concentrations of magnesium ions.
Ludwig P; Petrich K; Schewe T; Diezel W
Biol Chem Hoppe Seyler; 1995 Dec; 376(12):739-44. PubMed ID: 9072050
[TBL] [Abstract][Full Text] [Related]
10. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
[TBL] [Abstract][Full Text] [Related]
11. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation.
Houghton PJ; Zarka R; de las Heras B; Hoult JR
Planta Med; 1995 Feb; 61(1):33-6. PubMed ID: 7700988
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Marshall PJ; Griswold DE; Breton J; Webb EF; Hillegass LM; Sarau HM; Newton J; Lee JC; Bender PE; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):813-24. PubMed ID: 1907824
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of thromboxane B2 and leukotriene B4 biosynthesis by two naturally occurring acetylenic fatty acids.
Croft KD; Beilin LJ; Ford GL
Biochim Biophys Acta; 1987 Oct; 921(3):621-4. PubMed ID: 2822134
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of 5-lipoxygenase and cyclo-oxygenase pathways of arachidonate metabolism in rat peritoneal leukocytes.
Moroney MA; Forder RA; Carey F; Hoult JR
Br J Pharmacol; 1990 Sep; 101(1):128-32. PubMed ID: 2178012
[TBL] [Abstract][Full Text] [Related]
16. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
17. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.
Kimble E; Kowalski T; White D; Raychauduri A; Pastor G; Chertock H; Lee W; Neale R; Hamdan A; Wasley J
Agents Actions; 1991 Sep; 34(1-2):125-8. PubMed ID: 1665286
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
[TBL] [Abstract][Full Text] [Related]
19. L-652,343, a novel dual cyclo/lipoxygenase inhibitor, inhibits LTB4-production by stimulated human polymorphonuclear cells but not by stimulated human whole blood.
Gresele P; Arnout J; Deckmyn H; Vermylen J
Biochem Pharmacol; 1987 Oct; 36(20):3529-31. PubMed ID: 2823826
[No Abstract] [Full Text] [Related]
20. Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro.
Moilanen E; Alanko J; Seppälä E; Vapaatalo H
Agents Actions; 1988 Jul; 24(3-4):387-94. PubMed ID: 2845746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
